IP Library Patent Application 16061527
Patent Application
App. No. 16/061,527

COMPOSITIONS COMPRISING 3'-O-GLUCURONIDE EPICATECHIN AND METHODS OF MAKING AND USING SUCH COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/061,527
Abstract

Compositions can comprise the flavanol metabolite 3′-O-glucuronide epicatechin (3GEC). In some embodiments, the amount of 3GEC is effective to increase energy expenditure, sympathetic nervous system activity, and/or fat oxidation. Such a composition can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In some embodiments, the composition can improve insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood and/or memory. In some embodiments, the composition can achieve a therapeutic effect selected from the group consisting of blood vessel dilation, reduced blood pressure, increased delivery of blood flow to tissues in the body, improvement of blood circulation, e.g. in brain, stimulation of protein synthesis, increased release of growth factors, enhanced immune function, and combinations thereof. In some embodiments, the composition can treat or prevent dysphagia, e.g., by provoking the swallowing reflex.

Claims (18)

1 . A method for treating or preventing high blood pressure comprising administering to an individual in need thereof or at risk thereof a composition comprising 3′-O-glucuronide epicatechin.

2 . The method of claim 1 wherein the composition is orally administered to the individual as a food product in which the 3′-O-glucuronide epicatechin is present in a concentration of at least 0.01 mg/g of the food product.

3 . The method of claim 1 wherein the composition is injected into the individual.

4 . The method of claim 1 wherein the composition is administered to the individual at least once a day for at least one week.

5 . The method of claim 1 wherein the 3′-O-glucuronide epicatechin is chemically synthesized.

6 - 10 . (canceled)

11 . A method for achieving a therapeutic effect in an individual, the therapeutic effect selected from the group consisting of preventing cardiovascular disease, blood vessel dilation, reduced blood pressure, increased delivery of blood flow to tissues in the body, improvement of blood circulation, improvement of blood brain circulation, stimulation of protein synthesis, increased release of growth factors, enhanced immune function, and combinations thereof, the method comprising administering to the individual a composition comprising 3′-O-glucuronide epicatechin.

12 . The method of claim 11 wherein the composition is orally administered to the individual as a food product in which the 3′-O-glucuronide epicatechin is present in a concentration of at least 0.01 mg/g of the food product.

13 . The method of claim 11 wherein the composition is injected into the individual.

14 . The method of claim 11 wherein the composition is administered to the individual at least once a day for at least one week.

15 . The method of claim 11 wherein the 3′-O-glucuronide epicatechin is chemically synthesized.

16 - 22 . (canceled)

23 . A method for treating or preventing obesity or overweight comprising administering to an individual in need thereof or at risk thereof a composition comprising 3′-O-glucuronide epicatechin.

24 . The method of claim 23 wherein the composition is administered to provide an amount of the 3′-O-glucuronide epicatechin that increases at least one characteristic selected from the group consisting of energy expenditure, sympathetic nervous system activity, and fat oxidation.

25 . The method of claim 23 wherein the composition is a food product in which the 3′-O-glucuronide epicatechin is present in a concentration of at least 0.01 mg/g of the food product.

26 . The method of claim 23 wherein the composition further comprises an additional ingredient in an amount effective to promote weight maintenance or weight loss.

27 . The method of claim 23 wherein the individual is participating in a weight loss program selected from the group consisting of a low-fat diet, a low-carbohydrate diet, a low-calorie diet, a very low-calorie diet, endurance training, strength training, and combinations thereof.

28 - 62 . (canceled)

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
MERGER Recorded Jul 25, 2019
From: NESTEC S.A.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 049859/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2019
From: ACTIS GORETTA, LUCAS; PATIN, AMAURY; MICHLIG GONZALEZ, STEPHANIE; CAMACHO, SUSANA; LEGRAND, COLINE; LE COUTRE, JOHANNES; CASTANEDA GUTIERREZ, EURIDICE; SILVA ZOLEZZI, IRMA
To: NESTEC S.A.
Reel/Frame 049860/0076 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →